Clearinghouse
Filter
Positive health, dignity and prevention for women and their babies
Women living with HIV from eight countries have shared their expertise to shape the content and design of the guide and it was formulated in direct response to a call from communities for up-to-date, evidence-based resources.
Positive Health, Dignity and Prevention for Women and their Babies: A treatment literacy guide for pregnant women and mothers living with HIV is intended for use by networks…
Poster: Positive Health, Dignity and Prevention for Women and their Babies
Women living with HIV from eight countries have shared their expertise to shape the content and design of the guide and it was formulated in direct response to a call from communities for up-to-date, evidence-based resources.
The guide has 12 modules covering issues ranging from human rights to treatment adherence and nutrition. It is made up of three separate tools:
facilitator’s manual…
Gay men and HIV/AIDS 2013 - Schwule Männer und HIV/AIDS 2013
The 10th survey on the health-related behavior of gay men and other men who have sex with men provides two essential findings. Firstly, although a total of condom use has declined in recent years, but this fact cannot be equated with a decreasing HIV-protective behavior. Rather, other protective strategies are applied, which can be interpreted as an adaptation to the good treatability of HIV…
Annual Review of the Human Rights Situation of Lesbian, Gay, Bisexual, Trans and Intersex People in Europe 2016
This Annual Review covers developments at national and international level between January and December 2015.
It is divided into two main sections: Institutional reviews provide an overview of developments at the United Nations, the Council of Europe, the European Union and the Organization for Security and Cooperation in Europe and the second section,
Country reviews, contains 49 chapters…
Accessing HIV prevention, testing, treatment care and support in Europe as a migrant with irregular status in Europe: A comparative 10-country legal survey
In the 2014-2015 project phase the European HIV Legal Forum produced a comparative legal report based on legal survey from 10 European countries (France, Germany, Greece, Hungary, Italy, the Netherlands, Poland, Serbia, Spain and the United Kingdom). The legal report also includes a collection of main international regulations in favour of the right to healthcare, leading European laws related to…
Leaflet: Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT)
This leaflet discribes the three-year project, which was launched in late 2015 with core funding from the European Union (EU), and is being implemented by 23 partners representing 18 EU Member States.
The overall aim of HA-REACT is to significantly contribute to the elimination of HIV and to reductions in cases of TB and viral hepatitis among PWID in the European Union by 2020. This objective is…
Guidlines for the screening, care and treatment of the persons with hepatitis C infection
These are the fist guidelines dealing with hepatitis C treatment produced by the World Health Organization (WHO) and complement existing guidance on the prevention of transmission of bloodborne viruses, including HCV. They are intended for policy-makers, government offiials, and others working in low- and middleincome countries who are developing programmes for the screening, care and treatment…
European Drug Report 2015: Trends and Developments
Changing dynamics in the heroin market, the latest implications of cannabis use and new features and dimensions of the stimulant and ‘new drugs’ scene are among the issues highlighted in the European Drug Report 2015: Trends and Developments. This years’ annual review reflects on 20 years of monitoring and examines the global influences and local ramifications of Europe’s ever-changing drugs…
Preventing opioid overdose deaths with take-home naloxone
This publication examines the case for distributing naloxone, an emergency medication, to people who inject opioids such as heroin and to others who might witness an opioid overdose. Through its capacity to reverse opioid overdose, naloxone can save lives if administered in time. This comprehensive review looks at opioid overdose and how naloxone counteracts it, and discusses the circumstances of…
Drug-related infectious diseases in Europe
This report provides an update on infectious diseases related to injecting drug use in Europe for the period up to June 2015. The report covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and the responses in the area. It includes highlights and new findings discussed during the indicator's annual expert meeting, held in Lisbon on 15 and 16…
New heroin-assisted treatment
The prescription of substitution drugs, such as methadone and buprenorphine, has become a mainstream, first-line treatment for opioid dependence, with around 700 000 of Europe’s 1.3 million problem opioid users receiving substitution treatment today. But a small minority of entrenched opioid users repeatedly fails to respond to interventions of this kind. Findings from international trials now…
ECDC and EMCDDA guidance. Prevention and control of infectious diseases among people who inject drugs
This joint guidance report explores good public health practices that can support effective policies to reduce infections. Common blood-borne viruses in this group include HIV, hepatitis B and hepatitis C. These are mainly spread through the sharing of needles, syringes and drug preparation equipment or unprotected sexual contacts.
Guidelines for testing HIV, viral hepatitis and other infections in injecting drug users
Infectious diseases are among the most serious health consequences of injecting drug use and can lead to significant healthcare costs. Injecting drug users are vulnerable to a range of infectious and communicable diseases through a variety of risk behaviours, and because of underlying conditions such as poor hygiene, homelessness and poverty. There is a recognised need for guidance on providing…
Harm reduction: evidence, impacts and challenges
The EMCDDA’s 10th scientific monograph, entitled Harm reduction: evidence, impacts and challenges provides a comprehensive overview of the harm reduction field. Part I of the monograph looks back at the emergence of harm reduction approaches and their diffusion, and explores the concept from different perspectives, including international organisations, academic researchers and drug users. Part…
Perspectives on drugs: Drug consumption rooms - an overview of provision and evidence
Supervised drug consumption facilities, where illicit drugs can be used under the supervision of trained staff, have been operating in Europe for the last three decades. These facilities primarily aim to reduce the acute risks of disease transmission through unhygienic injecting, prevent drug-related overdose deaths and connect high-risk drug users with addiction treatment and other health and…
Perspectives on drugs: Health and social responses for methamphetamine users in Europe
Methamphetamine is an established stimulant drug in many parts of the world (e.g. South-east Asia, US), where it has long caused major public health problems. While methamphetamine use in Europe has historically been confined to the Czech Republic and Slovakia, new pockets and patterns of use are now emerging elsewhere in the EU, in diverse populations. In this analysis, we look at challenges for…
Perspectives on drugs: Hepatitis C Treatment for Injecting Drug Users
Transmitted through the sharing of needles, syringes and other injecting equipment, hepatitis C is the most common infectious disease among injecting drug users in Europe today.In this analysis, the EMCDDA looks at some of the positive advances in treating the disease, including a new generation of medicines.
Part of the ‘Perspectives on drugs’ (PODs) series, launched alongside the annual…
Perspectives on drugs: Preventing overdose deaths in Europe
It is estimated that over 70 000 lives were lost to drug overdoses in Europe in the first decade of the 21st Century. Reducing drug-related deaths, therefore, remains a major challenge for public health policy. This analysis describes some of the factors that increase the risk of fatal and non-fatal overdoses and a number of interventions developed to prevent these events.
Part of the ‘…
Civil Society Guide to EU Funding for Health in EECA
How to leverage European Union funding for health in Eastern Europe & Central Asia?
This guide provides readers with a basic overview of mechanisms and process to access funding at EU-level. It also present a series of recommendations that could help civil society to apply for EU funding for TB, HIV and harm reduction. It hope that this research could contribute to unveil the full potential…
Do no harm - Health, human rights and people who use drugs
Evidence supports the need for a shift in the global approach to drug use. In this report, Do no harm: health, human rights and people who use drugs, UNAIDS shows what works to reduce the impact of HIV and other harms related to drug use. Countries that have moved away from laws and policies that are harmful to people who use drugs and that have increased investment in harm reduction have reduced…
The Case for a Harm Reduction Decade: Progress, potential and paradigm shifts
Published biennially since 2008, the Global State of Harm Reduction is the leading independent resource monitoring the international harm reduction response.
The April 2016 UN General Assembly Special Session on the World Drug Problem coincides with the tenth anniversary of the start of the Global State of Harm Reduction project, and offers a significant opportunity to reflect on the past decade…
Road to Success: Towards Sustainable Harm Reduction Financing
This report analyses the current state of harm reduction investment and services for people who inject drugs in East Europe and Central Asia (EECA): Belarus, Georgia, Kazakhstan, Lithuania, Moldova, and Tajikistan. Monitoring of harm reduction services and investments in harm reduction programs has been conducted within the Regional Program “Harm Reduction Works – Funded It!” being implemented by…
REPORT: HIV, HCV, TB AND HARM REDUCTION IN PRISONS
This report is part of the European Union co-funded project “Improving Prison Conditions by Strengthening Infectious Disease Monitoring”, led by Harm Reduction International. The project aims to reduce ill treatment of people in detention and improve prison conditions through more comprehensive and standardised monitoring of the human immunodeficiency virus (HIV), hepatitis C virus (HCV),…
Manual for the development and assessment of national viral hepatitis plans: a provisional document
The purpose of this manual is to provide guidance to public health professionals tasked with managing a response to viral hepatitis. As every country’s needs are different with respect to its epidemiology and the current level of response, people would use this manual in different ways. This manual is intended:
• to help think more comprehensively about the hepatitis response in a country;
• to…
IQhiv Mission statement: Improving Quality in HIV Prevention in Europe
IQhiv is an initiative of civil society, government, academic and international organizations investigating quality assurance and quality improvement practices relevant to HIV prevention programs and projects across Europe. In 2008, WHO Europe and the Federal Centre for Health Education (BZgA) in Germany jointly organised the first Europe-wide conference on quality in HIV prevention in Berlin,…
TUBIDU Report: Assessment on HIV and TB knowledge and the barriers related to access to care among vulnerable groups
The current report provides an overview of the cross-sectional study among IDUs conducted in Bulgaria, Romania and the Baltic countries. The study focused on identifying knowledge about TB and HIV as well as barriers to access to TB- and HIV-related health care services. The aim was to provide information for programmatic development and policy-making, in order to improve access to TB- and HIV-…
TUBIDU Report: Empowering the Public Health System and Civil Society to Fight the Tuberculosis Epidemic among Vulnerable Groups
The general objective of the project is to contribute to the prevention of the tuberculosis (TB) epidemic among people who inject drugs (PWID) and the people living with HIV (PLHIV) in the participating countries. The strategic objectives include empowering the public health system and civil society, and enhancing collaboration between various stakeholders in the field in order to tackle TB.
TUBIDU Training Outline
For trainings based on TUBIDU Handbook for community based organizations on tuberculosis services for people who inject drugs.
TUBIDU Handbook for community based organisations on tuberculosis services for people who inject drugs
This handbook has been developed in the framework of the project TUBIDU: Empowering the Public Health System and Civil Society to Fight the Tuberculosis Epidemic among Vulnerable Groups. This European Union (EU) project is funded by the “Programme of Community Action in the Field of Health (2008-2013)” and includes seven participating organizations from six EU countries. Five collaborating…
TUBIDU: Guidance for community based organisations on tuberculosis services for people who inject drugs
People who inject drugs (PWID) are often among the most vulnerable and socially excluded people in any society and are therefore exposed to many risk factors which put them at high risk of contracting tuberculosis (TB). When compared with the general population, people who use illicit drugs have a higher risk of developing active TB disease, once infected.3,4 Although the higher risk of TB…